

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.36186541 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.36186541 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.27435305 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.27435305 |
| 5 | desmosome organization (GO:0002934) | 5.54820483 |
| 6 | negative regulation of fibrinolysis (GO:0051918) | 5.34087661 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 5.29296659 |
| 8 | regulation of fibrinolysis (GO:0051917) | 4.92050363 |
| 9 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.89523964 |
| 10 | protein carboxylation (GO:0018214) | 4.89523964 |
| 11 | sulfur amino acid catabolic process (GO:0000098) | 4.85361857 |
| 12 | Golgi transport vesicle coating (GO:0048200) | 4.84531963 |
| 13 | COPI coating of Golgi vesicle (GO:0048205) | 4.84531963 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.77025261 |
| 15 | bile acid biosynthetic process (GO:0006699) | 4.74661380 |
| 16 | hemidesmosome assembly (GO:0031581) | 4.62692038 |
| 17 | cysteine metabolic process (GO:0006534) | 4.62458814 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 4.51806926 |
| 19 | regulation of protein activation cascade (GO:2000257) | 4.40224354 |
| 20 | kynurenine metabolic process (GO:0070189) | 4.38944416 |
| 21 | tryptophan catabolic process (GO:0006569) | 4.38337867 |
| 22 | indole-containing compound catabolic process (GO:0042436) | 4.38337867 |
| 23 | indolalkylamine catabolic process (GO:0046218) | 4.38337867 |
| 24 | urea cycle (GO:0000050) | 4.38011393 |
| 25 | urea metabolic process (GO:0019627) | 4.38011393 |
| 26 | intestinal cholesterol absorption (GO:0030299) | 4.33135711 |
| 27 | high-density lipoprotein particle remodeling (GO:0034375) | 4.21978327 |
| 28 | glyoxylate metabolic process (GO:0046487) | 4.19866469 |
| 29 | regulation of complement activation (GO:0030449) | 4.15338870 |
| 30 | tryptophan metabolic process (GO:0006568) | 4.15311930 |
| 31 | homocysteine metabolic process (GO:0050667) | 4.12526756 |
| 32 | bile acid metabolic process (GO:0008206) | 4.09723665 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.07913309 |
| 34 | complement activation, alternative pathway (GO:0006957) | 4.07398411 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 4.00953680 |
| 36 | cellular ketone body metabolic process (GO:0046950) | 3.90779056 |
| 37 | regulation of water loss via skin (GO:0033561) | 3.90566443 |
| 38 | aromatic amino acid family metabolic process (GO:0009072) | 3.88690760 |
| 39 | reverse cholesterol transport (GO:0043691) | 3.88206510 |
| 40 | regulation of triglyceride catabolic process (GO:0010896) | 3.85083125 |
| 41 | lysine catabolic process (GO:0006554) | 3.84929158 |
| 42 | lysine metabolic process (GO:0006553) | 3.84929158 |
| 43 | cellular glucuronidation (GO:0052695) | 3.82112237 |
| 44 | fibrinolysis (GO:0042730) | 3.80696966 |
| 45 | acylglycerol homeostasis (GO:0055090) | 3.78285868 |
| 46 | triglyceride homeostasis (GO:0070328) | 3.78285868 |
| 47 | epoxygenase P450 pathway (GO:0019373) | 3.78253153 |
| 48 | regulation of cholesterol homeostasis (GO:2000188) | 3.74328807 |
| 49 | cell adhesion mediated by integrin (GO:0033627) | 3.73986679 |
| 50 | regulation of bile acid biosynthetic process (GO:0070857) | 3.73247872 |
| 51 | bile acid and bile salt transport (GO:0015721) | 3.69691874 |
| 52 | coenzyme catabolic process (GO:0009109) | 3.69666325 |
| 53 | drug catabolic process (GO:0042737) | 3.68274409 |
| 54 | tyrosine metabolic process (GO:0006570) | 3.67889146 |
| 55 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.65849604 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 3.57505704 |
| 57 | regulation of cholesterol esterification (GO:0010872) | 3.55865084 |
| 58 | negative regulation of sterol transport (GO:0032372) | 3.55845280 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 3.55845280 |
| 60 | COPII vesicle coating (GO:0048208) | 3.52657839 |
| 61 | uronic acid metabolic process (GO:0006063) | 3.52152213 |
| 62 | glucuronate metabolic process (GO:0019585) | 3.52152213 |
| 63 | cellular modified amino acid catabolic process (GO:0042219) | 3.50369781 |
| 64 | serine family amino acid catabolic process (GO:0009071) | 3.50092200 |
| 65 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.49408613 |
| 66 | type B pancreatic cell proliferation (GO:0044342) | 3.47903042 |
| 67 | plasma lipoprotein particle remodeling (GO:0034369) | 3.47815810 |
| 68 | protein-lipid complex remodeling (GO:0034368) | 3.47815810 |
| 69 | macromolecular complex remodeling (GO:0034367) | 3.47815810 |
| 70 | skin morphogenesis (GO:0043589) | 3.47537721 |
| 71 | establishment of skin barrier (GO:0061436) | 3.45891518 |
| 72 | regulation of plasminogen activation (GO:0010755) | 3.45867401 |
| 73 | alpha-amino acid catabolic process (GO:1901606) | 3.45511352 |
| 74 | flavonoid metabolic process (GO:0009812) | 3.43464706 |
| 75 | aldehyde catabolic process (GO:0046185) | 3.40642436 |
| 76 | phospholipid efflux (GO:0033700) | 3.39953108 |
| 77 | prostate gland growth (GO:0060736) | 3.37564996 |
| 78 | glutamate metabolic process (GO:0006536) | 3.35541484 |
| 79 | ketone body metabolic process (GO:1902224) | 3.33009243 |
| 80 | plasma lipoprotein particle clearance (GO:0034381) | 3.32955241 |
| 81 | cellular amino acid catabolic process (GO:0009063) | 3.28808442 |
| 82 | mammary gland epithelial cell differentiation (GO:0060644) | 3.28593443 |
| 83 | intestinal absorption (GO:0050892) | 3.24711676 |
| 84 | cholesterol efflux (GO:0033344) | 3.23508461 |
| 85 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 3.21678601 |
| 86 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.21595197 |
| 87 | negative regulation of protein activation cascade (GO:2000258) | 3.21455487 |
| 88 | iron ion import (GO:0097286) | 3.19220361 |
| 89 | negative regulation of lipase activity (GO:0060192) | 3.19004045 |
| 90 | drug metabolic process (GO:0017144) | 3.17732892 |
| 91 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.16739513 |
| 92 | ovulation from ovarian follicle (GO:0001542) | 3.15110000 |
| 93 | opsonization (GO:0008228) | 3.13834400 |
| 94 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.13507003 |
| 95 | arginine metabolic process (GO:0006525) | 3.10758049 |
| 96 | ethanol oxidation (GO:0006069) | 3.10001113 |
| 97 | indolalkylamine metabolic process (GO:0006586) | 3.08840768 |
| 98 | benzene-containing compound metabolic process (GO:0042537) | 3.07834027 |
| 99 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.07702004 |
| 100 | exogenous drug catabolic process (GO:0042738) | 3.06720394 |
| 101 | cholesterol homeostasis (GO:0042632) | 3.06193853 |
| 102 | lipoprotein metabolic process (GO:0042157) | 3.05870535 |
| 103 | cofactor catabolic process (GO:0051187) | 3.05263994 |
| 104 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.04502894 |
| 105 | sterol homeostasis (GO:0055092) | 3.03720993 |
| 106 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.03002781 |
| 107 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.01185830 |
| 108 | positive regulation of lipid catabolic process (GO:0050996) | 2.98104067 |
| 109 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.95459928 |
| 110 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.95459928 |
| 111 | macroautophagy (GO:0016236) | 2.95311718 |
| 112 | epithelial cell-cell adhesion (GO:0090136) | 2.93153911 |
| 113 | response to nitrosative stress (GO:0051409) | 2.92801295 |
| 114 | complement activation, classical pathway (GO:0006958) | 2.92797773 |
| 115 | serine family amino acid metabolic process (GO:0009069) | 2.91555849 |
| 116 | cytolysis (GO:0019835) | 2.91080592 |
| 117 | acute-phase response (GO:0006953) | 2.91014076 |
| 118 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.90650367 |
| 119 | organic acid catabolic process (GO:0016054) | 2.88973490 |
| 120 | carboxylic acid catabolic process (GO:0046395) | 2.88973490 |
| 121 | plasma lipoprotein particle assembly (GO:0034377) | 2.88630994 |
| 122 | imidazole-containing compound metabolic process (GO:0052803) | 2.87432891 |
| 123 | drug transmembrane transport (GO:0006855) | 2.86869320 |
| 124 | protein retention in ER lumen (GO:0006621) | 2.84021541 |
| 125 | multicellular organismal water homeostasis (GO:0050891) | 2.84016297 |
| 126 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.84003392 |
| 127 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.83963714 |
| 128 | cell-substrate junction assembly (GO:0007044) | 2.83295571 |
| 129 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.82720167 |
| 130 | tonic smooth muscle contraction (GO:0014820) | 2.70185586 |
| 131 | endocardial cushion development (GO:0003197) | 2.67534013 |
| 132 | mammary gland alveolus development (GO:0060749) | 2.67285642 |
| 133 | lung lobe morphogenesis (GO:0060463) | 2.67123677 |
| 134 | negative regulation of complement activation (GO:0045916) | 2.66046420 |
| 135 | vesicle coating (GO:0006901) | 2.65548780 |
| 136 | surfactant homeostasis (GO:0043129) | 2.63760589 |
| 137 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.62068226 |
| 138 | heparin biosynthetic process (GO:0030210) | 2.57716231 |
| 139 | heparin metabolic process (GO:0030202) | 2.57716231 |
| 140 | tight junction assembly (GO:0070830) | 2.54255103 |
| 141 | ER overload response (GO:0006983) | 2.52076588 |
| 142 | water homeostasis (GO:0030104) | 2.50367991 |
| 143 | keratan sulfate catabolic process (GO:0042340) | 2.49455738 |
| 144 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.48230064 |
| 145 | basement membrane organization (GO:0071711) | 2.48138097 |
| 146 | biotin metabolic process (GO:0006768) | 2.47072240 |
| 147 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.47070490 |
| 148 | intestinal epithelial cell development (GO:0060576) | 2.46401875 |
| 149 | endocrine hormone secretion (GO:0060986) | 2.45788089 |
| 150 | L-serine transport (GO:0015825) | 2.42580585 |
| 151 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.40643907 |
| 152 | artery smooth muscle contraction (GO:0014824) | 2.40547833 |
| 153 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.40401103 |
| 154 | smooth muscle tissue development (GO:0048745) | 2.39233612 |
| 155 | collagen fibril organization (GO:0030199) | 2.34270184 |
| 156 | cardiac right ventricle morphogenesis (GO:0003215) | 2.33736824 |
| 157 | polarized epithelial cell differentiation (GO:0030859) | 2.32596200 |
| 158 | regulation of hippo signaling (GO:0035330) | 2.31765771 |
| 159 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.29738775 |
| 160 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.29417575 |
| 161 | embryo implantation (GO:0007566) | 2.27963890 |
| 162 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.27928080 |
| 163 | polyketide metabolic process (GO:0030638) | 2.26148204 |
| 164 | doxorubicin metabolic process (GO:0044598) | 2.26148204 |
| 165 | daunorubicin metabolic process (GO:0044597) | 2.26148204 |
| 166 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.24346961 |
| 167 | negative regulation of fatty acid transport (GO:2000192) | 2.23897343 |
| 168 | regulation of protein localization to cell surface (GO:2000008) | 2.23493705 |
| 169 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.23266767 |
| 170 | protein localization to endosome (GO:0036010) | 2.22989716 |
| 171 | retinal metabolic process (GO:0042574) | 2.22526041 |
| 172 | regulation of extracellular matrix disassembly (GO:0010715) | 2.22519199 |
| 173 | epithelial cell maturation (GO:0002070) | 2.21299617 |
| 174 | peptidyl-proline hydroxylation (GO:0019511) | 2.20643422 |
| 175 | positive regulation of actin filament depolymerization (GO:0030836) | 2.20340384 |
| 176 | protein hydroxylation (GO:0018126) | 2.19740955 |
| 177 | amyloid precursor protein metabolic process (GO:0042982) | 2.19499391 |
| 178 | endodermal cell differentiation (GO:0035987) | 2.19338949 |
| 179 | amyloid precursor protein catabolic process (GO:0042987) | 2.18219053 |
| 180 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.16952071 |
| 181 | gap junction assembly (GO:0016264) | 2.16102273 |
| 182 | protein heterotrimerization (GO:0070208) | 2.16100466 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.26415609 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.98037739 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.10338378 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.71464107 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.21487430 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.62687439 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.54795181 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.44697960 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.32751376 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.15775967 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.06826253 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.96129980 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.60840872 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.57326616 |
| 15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.12327158 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94010319 |
| 17 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.85275180 |
| 18 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.83461892 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79076271 |
| 20 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.72346429 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.69074825 |
| 22 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.66571316 |
| 23 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.63050696 |
| 24 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.63050696 |
| 25 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.62742985 |
| 26 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.53260264 |
| 27 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.53133170 |
| 28 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.47471824 |
| 29 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.40214377 |
| 30 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.40044066 |
| 31 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.32865690 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.32098449 |
| 33 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32096964 |
| 34 | CJUN_26792858_Chip-Seq_BT549_Human | 1.30551717 |
| 35 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.28526405 |
| 36 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27313368 |
| 37 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25340195 |
| 38 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22923306 |
| 39 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21073834 |
| 40 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.19932243 |
| 41 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.19057441 |
| 42 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.17871047 |
| 43 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.17150658 |
| 44 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15711462 |
| 45 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.12540728 |
| 46 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.11592407 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09227670 |
| 48 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.09088718 |
| 49 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.08914993 |
| 50 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.07861716 |
| 51 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06474541 |
| 52 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.05108571 |
| 53 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.04724950 |
| 54 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.03300508 |
| 55 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03149907 |
| 56 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.01937509 |
| 57 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.01371176 |
| 58 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.97928231 |
| 59 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.97385431 |
| 60 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97369053 |
| 61 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.96619479 |
| 62 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95210631 |
| 63 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.94294918 |
| 64 | ATF3_27146783_Chip-Seq_COLON_Human | 0.93779206 |
| 65 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.93607624 |
| 66 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.93476216 |
| 67 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92330985 |
| 68 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.90005786 |
| 69 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.89600279 |
| 70 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89478043 |
| 71 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89411552 |
| 72 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.89088296 |
| 73 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.87853702 |
| 74 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.87305489 |
| 75 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86781195 |
| 76 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86268321 |
| 77 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.85012164 |
| 78 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.85012164 |
| 79 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84478937 |
| 80 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84327092 |
| 81 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.83376696 |
| 82 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.83376696 |
| 83 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83282733 |
| 84 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.82719905 |
| 85 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.82116212 |
| 86 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.81772797 |
| 87 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81031956 |
| 88 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.79640195 |
| 89 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.79624110 |
| 90 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.78866038 |
| 91 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.77762838 |
| 92 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.76430693 |
| 93 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.76148319 |
| 94 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.75053768 |
| 95 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.74593505 |
| 96 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.74557558 |
| 97 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.74526134 |
| 98 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.74168068 |
| 99 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.72948105 |
| 100 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.72735958 |
| 101 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.72160864 |
| 102 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71891068 |
| 103 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.71859274 |
| 104 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70963346 |
| 105 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70314236 |
| 106 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.70094597 |
| 107 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.69806686 |
| 108 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.67603658 |
| 109 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.66226951 |
| 110 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.66206432 |
| 111 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.65676856 |
| 112 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.65092151 |
| 113 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.64738787 |
| 114 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.64658187 |
| 115 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63698119 |
| 116 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.62981843 |
| 117 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.61483197 |
| 118 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61168305 |
| 119 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.61070202 |
| 120 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.58657617 |
| 121 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.58651350 |
| 122 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58196292 |
| 123 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.57456830 |
| 124 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.57444321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.87519475 |
| 2 | MP0005360_urolithiasis | 5.86369527 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.03321649 |
| 4 | MP0005365_abnormal_bile_salt | 4.69859751 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.03186165 |
| 6 | MP0003252_abnormal_bile_duct | 3.85508158 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 3.24337446 |
| 8 | MP0005083_abnormal_biliary_tract | 3.21361257 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.04841281 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.99424446 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.86041124 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 2.74182757 |
| 13 | MP0003195_calcinosis | 2.68727881 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.57406967 |
| 15 | MP0005248_abnormal_Harderian_gland | 2.40838548 |
| 16 | MP0009840_abnormal_foam_cell | 2.36453407 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 2.32770751 |
| 18 | MP0001346_abnormal_lacrimal_gland | 2.20102131 |
| 19 | MP0005084_abnormal_gallbladder_morpholo | 2.16453457 |
| 20 | MP0003941_abnormal_skin_development | 2.14787846 |
| 21 | MP0005332_abnormal_amino_acid | 2.12960507 |
| 22 | MP0005275_abnormal_skin_tensile | 2.06389874 |
| 23 | MP0009384_cardiac_valve_regurgitation | 2.02359381 |
| 24 | MP0002098_abnormal_vibrissa_morphology | 1.89172929 |
| 25 | MP0003868_abnormal_feces_composition | 1.81555521 |
| 26 | MP0005501_abnormal_skin_physiology | 1.80977672 |
| 27 | MP0010678_abnormal_skin_adnexa | 1.77325822 |
| 28 | MP0005220_abnormal_exocrine_pancreas | 1.74178084 |
| 29 | MP0004019_abnormal_vitamin_homeostasis | 1.69027350 |
| 30 | MP0000627_abnormal_mammary_gland | 1.61019117 |
| 31 | MP0001881_abnormal_mammary_gland | 1.56515811 |
| 32 | MP0000762_abnormal_tongue_morphology | 1.55868249 |
| 33 | MP0010368_abnormal_lymphatic_system | 1.52567819 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.52419335 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.48131212 |
| 36 | MP0000467_abnormal_esophagus_morphology | 1.46542997 |
| 37 | MP0000609_abnormal_liver_physiology | 1.45958793 |
| 38 | MP0002928_abnormal_bile_duct | 1.42550637 |
| 39 | MP0003950_abnormal_plasma_membrane | 1.42435286 |
| 40 | MP0004233_abnormal_muscle_weight | 1.33461651 |
| 41 | MP0005379_endocrine/exocrine_gland_phen | 1.32418365 |
| 42 | MP0002295_abnormal_pulmonary_circulatio | 1.29885464 |
| 43 | MP0000383_abnormal_hair_follicle | 1.29112705 |
| 44 | MP0002060_abnormal_skin_morphology | 1.27051447 |
| 45 | MP0003279_aneurysm | 1.26444190 |
| 46 | MP0005623_abnormal_meninges_morphology | 1.25607262 |
| 47 | MP0001216_abnormal_epidermal_layer | 1.24814154 |
| 48 | MP0005319_abnormal_enzyme/_coenzyme | 1.22894948 |
| 49 | MP0000377_abnormal_hair_follicle | 1.21268558 |
| 50 | MP0002877_abnormal_melanocyte_morpholog | 1.18323245 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.16325588 |
| 52 | MP0009643_abnormal_urine_homeostasis | 1.15599935 |
| 53 | MP0001661_extended_life_span | 1.12969470 |
| 54 | MP0001919_abnormal_reproductive_system | 1.11559265 |
| 55 | MP0000013_abnormal_adipose_tissue | 1.10222172 |
| 56 | MP0005058_abnormal_lysosome_morphology | 1.10104676 |
| 57 | MP0000767_abnormal_smooth_muscle | 1.08109134 |
| 58 | MP0003329_amyloid_beta_deposits | 1.07962890 |
| 59 | MP0005508_abnormal_skeleton_morphology | 1.06905485 |
| 60 | MP0001849_ear_inflammation | 1.05578802 |
| 61 | MP0003283_abnormal_digestive_organ | 1.04963117 |
| 62 | MP0004272_abnormal_basement_membrane | 1.04140387 |
| 63 | MP0002108_abnormal_muscle_morphology | 1.03110641 |
| 64 | MP0000003_abnormal_adipose_tissue | 1.02193796 |
| 65 | MP0002909_abnormal_adrenal_gland | 1.02083025 |
| 66 | MP0009780_abnormal_chondrocyte_physiolo | 0.99403246 |
| 67 | MP0005503_abnormal_tendon_morphology | 0.98547218 |
| 68 | MP0005409_darkened_coat_color | 0.98103818 |
| 69 | MP0002168_other_aberrant_phenotype | 0.98055834 |
| 70 | MP0005023_abnormal_wound_healing | 0.97700472 |
| 71 | MP0006054_spinal_hemorrhage | 0.97698238 |
| 72 | MP0000462_abnormal_digestive_system | 0.97682585 |
| 73 | MP0008004_abnormal_stomach_pH | 0.96727319 |
| 74 | MP0005408_hypopigmentation | 0.95657398 |
| 75 | MP0001958_emphysema | 0.95612948 |
| 76 | MP0004264_abnormal_extraembryonic_tissu | 0.95210147 |
| 77 | MP0003011_delayed_dark_adaptation | 0.93831517 |
| 78 | MP0002796_impaired_skin_barrier | 0.89934282 |
| 79 | MP0009053_abnormal_anal_canal | 0.87859000 |
| 80 | MP0000604_amyloidosis | 0.87584876 |
| 81 | MP0009697_abnormal_copulation | 0.84382585 |
| 82 | MP0003936_abnormal_reproductive_system | 0.84099965 |
| 83 | MP0009379_abnormal_foot_pigmentation | 0.83365581 |
| 84 | MP0005395_other_phenotype | 0.82946119 |
| 85 | MP0000598_abnormal_liver_morphology | 0.81136608 |
| 86 | MP0001944_abnormal_pancreas_morphology | 0.80878058 |
| 87 | MP0002089_abnormal_postnatal_growth/wei | 0.80805602 |
| 88 | MP0003566_abnormal_cell_adhesion | 0.79950153 |
| 89 | MP0001764_abnormal_homeostasis | 0.79643391 |
| 90 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79477396 |
| 91 | MP0005636_abnormal_mineral_homeostasis | 0.79342884 |
| 92 | MP0001879_abnormal_lymphatic_vessel | 0.78708530 |
| 93 | MP0002896_abnormal_bone_mineralization | 0.78356610 |
| 94 | MP0010352_gastrointestinal_tract_polyps | 0.77688074 |
| 95 | MP0000534_abnormal_ureter_morphology | 0.76405916 |
| 96 | MP0002254_reproductive_system_inflammat | 0.75671953 |
| 97 | MP0000538_abnormal_urinary_bladder | 0.74730200 |
| 98 | MP0000163_abnormal_cartilage_morphology | 0.74328698 |
| 99 | MP0001243_abnormal_dermal_layer | 0.74147435 |
| 100 | MP0001542_abnormal_bone_strength | 0.72854045 |
| 101 | MP0000566_synostosis | 0.72227700 |
| 102 | MP0000613_abnormal_salivary_gland | 0.71821436 |
| 103 | MP0003942_abnormal_urinary_system | 0.71033618 |
| 104 | MP0009931_abnormal_skin_appearance | 0.69914238 |
| 105 | MP0005595_abnormal_vascular_smooth | 0.68582359 |
| 106 | MP0010386_abnormal_urinary_bladder | 0.68003110 |
| 107 | MP0001756_abnormal_urination | 0.67914440 |
| 108 | MP0005257_abnormal_intraocular_pressure | 0.67758644 |
| 109 | MP0002837_dystrophic_cardiac_calcinosis | 0.67667649 |
| 110 | MP0002078_abnormal_glucose_homeostasis | 0.67279183 |
| 111 | MP0003186_abnormal_redox_activity | 0.65899155 |
| 112 | MP0000537_abnormal_urethra_morphology | 0.64834977 |
| 113 | MP0002876_abnormal_thyroid_physiology | 0.64363264 |
| 114 | MP0005164_abnormal_response_to | 0.61041348 |
| 115 | MP0004782_abnormal_surfactant_physiolog | 0.60534562 |
| 116 | MP0005165_increased_susceptibility_to | 0.58696258 |
| 117 | MP0003045_fibrosis | 0.58220546 |
| 118 | MP0003091_abnormal_cell_migration | 0.57982896 |
| 119 | MP0005647_abnormal_sex_gland | 0.57501679 |
| 120 | MP0001664_abnormal_digestion | 0.57031853 |
| 121 | MP0009764_decreased_sensitivity_to | 0.56305915 |
| 122 | MP0003453_abnormal_keratinocyte_physiol | 0.56111621 |
| 123 | MP0009642_abnormal_blood_homeostasis | 0.56062996 |
| 124 | MP0004883_abnormal_blood_vessel | 0.55847820 |
| 125 | MP0005376_homeostasis/metabolism_phenot | 0.54154440 |
| 126 | MP0005451_abnormal_body_composition | 0.54049943 |
| 127 | MP0010030_abnormal_orbit_morphology | 0.52078019 |
| 128 | MP0001765_abnormal_ion_homeostasis | 0.51120910 |
| 129 | MP0009763_increased_sensitivity_to | 0.50653255 |
| 130 | MP0005187_abnormal_penis_morphology | 0.49781265 |
| 131 | MP0000579_abnormal_nail_morphology | 0.49114147 |
| 132 | MP0002282_abnormal_trachea_morphology | 0.47485898 |
| 133 | MP0000427_abnormal_hair_cycle | 0.46781314 |
| 134 | MP0003638_abnormal_response/metabolism_ | 0.45925859 |
| 135 | MP0003959_abnormal_lean_body | 0.45256785 |
| 136 | MP0005448_abnormal_energy_balance | 0.45163659 |
| 137 | MP0010771_integument_phenotype | 0.43198359 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.26829662 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.21215436 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.72746926 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.39467939 |
| 5 | Xanthomatosis (HP:0000991) | 5.22250022 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 4.95815272 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.61867804 |
| 8 | Protrusio acetabuli (HP:0003179) | 4.12845113 |
| 9 | Hypolipoproteinemia (HP:0010981) | 3.93152202 |
| 10 | Complement deficiency (HP:0004431) | 3.89043071 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 3.86942765 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 3.86156170 |
| 13 | Fat malabsorption (HP:0002630) | 3.77982823 |
| 14 | Premature rupture of membranes (HP:0001788) | 3.63826901 |
| 15 | Gout (HP:0001997) | 3.61158126 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.59195086 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 3.58972023 |
| 18 | Abnormality of the intrinsic pathway (HP:0010989) | 3.54738938 |
| 19 | Sparse lateral eyebrow (HP:0005338) | 3.54260388 |
| 20 | Menorrhagia (HP:0000132) | 3.53409786 |
| 21 | Right ventricular cardiomyopathy (HP:0011663) | 3.44923240 |
| 22 | Abnormality of nail color (HP:0100643) | 3.42446964 |
| 23 | Conjugated hyperbilirubinemia (HP:0002908) | 3.40166037 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.39847606 |
| 25 | Cervical subluxation (HP:0003308) | 3.36341676 |
| 26 | Ketosis (HP:0001946) | 3.28245357 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.28104906 |
| 28 | Hyperammonemia (HP:0001987) | 3.26014617 |
| 29 | Vascular tortuosity (HP:0004948) | 3.22926924 |
| 30 | Arterial tortuosity (HP:0005116) | 3.14850201 |
| 31 | Broad metatarsal (HP:0001783) | 3.12667712 |
| 32 | Epidermoid cyst (HP:0200040) | 3.12562411 |
| 33 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.12175487 |
| 34 | Follicular hyperkeratosis (HP:0007502) | 3.12127023 |
| 35 | Abnormality of complement system (HP:0005339) | 3.07112848 |
| 36 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.06833253 |
| 37 | Peritonitis (HP:0002586) | 2.95751821 |
| 38 | Abnormality of methionine metabolism (HP:0010901) | 2.87262382 |
| 39 | Steatorrhea (HP:0002570) | 2.85622560 |
| 40 | Concave nail (HP:0001598) | 2.84687852 |
| 41 | Hyperglycinemia (HP:0002154) | 2.79342236 |
| 42 | Skin nodule (HP:0200036) | 2.76267241 |
| 43 | Abnormality of purine metabolism (HP:0004352) | 2.73477262 |
| 44 | Malnutrition (HP:0004395) | 2.72666185 |
| 45 | Flat capital femoral epiphysis (HP:0003370) | 2.71348909 |
| 46 | Oligomenorrhea (HP:0000876) | 2.69186631 |
| 47 | Pili torti (HP:0003777) | 2.68978137 |
| 48 | Ileus (HP:0002595) | 2.68441757 |
| 49 | Ketoacidosis (HP:0001993) | 2.67626834 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.65936231 |
| 51 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.65936231 |
| 52 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.65868879 |
| 53 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.65645422 |
| 54 | Joint hemorrhage (HP:0005261) | 2.63238620 |
| 55 | Esophageal varix (HP:0002040) | 2.62473141 |
| 56 | Vertebral compression fractures (HP:0002953) | 2.61141667 |
| 57 | Cardiovascular calcification (HP:0011915) | 2.53219484 |
| 58 | Spontaneous abortion (HP:0005268) | 2.49746770 |
| 59 | Hypercholesterolemia (HP:0003124) | 2.49607113 |
| 60 | Abnormality of nucleobase metabolism (HP:0010932) | 2.47376494 |
| 61 | Abnormality of glycine metabolism (HP:0010895) | 2.46959849 |
| 62 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.46959849 |
| 63 | Late onset (HP:0003584) | 2.44944308 |
| 64 | Hepatocellular carcinoma (HP:0001402) | 2.44555729 |
| 65 | Hyperglycinuria (HP:0003108) | 2.42583329 |
| 66 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.41769528 |
| 67 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.41769528 |
| 68 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.41769528 |
| 69 | Atrophic scars (HP:0001075) | 2.41607531 |
| 70 | Myocardial infarction (HP:0001658) | 2.41187789 |
| 71 | Infantile muscular hypotonia (HP:0008947) | 2.38060140 |
| 72 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.36296838 |
| 73 | Osteolytic defects of the hand bones (HP:0009699) | 2.36296838 |
| 74 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.35013818 |
| 75 | Ankle contracture (HP:0006466) | 2.34957851 |
| 76 | Alopecia of scalp (HP:0002293) | 2.32827907 |
| 77 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.32010497 |
| 78 | Blue sclerae (HP:0000592) | 2.32007159 |
| 79 | Flat acetabular roof (HP:0003180) | 2.31895452 |
| 80 | Mitral stenosis (HP:0001718) | 2.29570598 |
| 81 | Aortic aneurysm (HP:0004942) | 2.28431169 |
| 82 | Acanthosis nigricans (HP:0000956) | 2.27852634 |
| 83 | Vascular calcification (HP:0004934) | 2.26562184 |
| 84 | Osteoarthritis (HP:0002758) | 2.25676637 |
| 85 | Hyperglycemia (HP:0003074) | 2.24784771 |
| 86 | Hypoplasia of dental enamel (HP:0006297) | 2.24361721 |
| 87 | Congenital glaucoma (HP:0001087) | 2.24341359 |
| 88 | Natal tooth (HP:0000695) | 2.24158159 |
| 89 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 2.23710443 |
| 90 | Termporal pattern (HP:0011008) | 2.23666982 |
| 91 | Insidious onset (HP:0003587) | 2.23666982 |
| 92 | Aortic dissection (HP:0002647) | 2.20000710 |
| 93 | Abnormality of dentin (HP:0010299) | 2.18831186 |
| 94 | Advanced eruption of teeth (HP:0006288) | 2.18724251 |
| 95 | Hypoglycemic seizures (HP:0002173) | 2.18384843 |
| 96 | Increased purine levels (HP:0004368) | 2.18136670 |
| 97 | Hyperuricemia (HP:0002149) | 2.18136670 |
| 98 | Curly hair (HP:0002212) | 2.17511347 |
| 99 | Spastic diplegia (HP:0001264) | 2.16305978 |
| 100 | Abnormal gallbladder physiology (HP:0012438) | 2.15727477 |
| 101 | Cholecystitis (HP:0001082) | 2.15727477 |
| 102 | Hyperbilirubinemia (HP:0002904) | 2.15301744 |
| 103 | Abnormal cartilage morphology (HP:0002763) | 2.14760558 |
| 104 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.13753497 |
| 105 | Ovoid vertebral bodies (HP:0003300) | 2.11959516 |
| 106 | Sensorimotor neuropathy (HP:0007141) | 2.09974120 |
| 107 | Abnormality of carpal bone ossification (HP:0006257) | 2.09098706 |
| 108 | Abnormal hair laboratory examination (HP:0003328) | 2.09090982 |
| 109 | Thin bony cortex (HP:0002753) | 2.07255639 |
| 110 | Fragile skin (HP:0001030) | 2.07163587 |
| 111 | Dysostosis multiplex (HP:0000943) | 2.07149577 |
| 112 | Soft skin (HP:0000977) | 2.06941833 |
| 113 | Abnormality of serum amino acid levels (HP:0003112) | 2.04238383 |
| 114 | Milia (HP:0001056) | 2.04057484 |
| 115 | Abnormal delivery (HP:0001787) | 2.01175150 |
| 116 | Lethargy (HP:0001254) | 2.00295095 |
| 117 | Exostoses (HP:0100777) | 2.00080828 |
| 118 | Abnormality of the Achilles tendon (HP:0005109) | 1.96824254 |
| 119 | Potter facies (HP:0002009) | 1.96519699 |
| 120 | Facial shape deformation (HP:0011334) | 1.96519699 |
| 121 | Biconcave vertebral bodies (HP:0004586) | 1.96146373 |
| 122 | Wormian bones (HP:0002645) | 1.96018151 |
| 123 | Spinal rigidity (HP:0003306) | 1.95583218 |
| 124 | Coxa vara (HP:0002812) | 1.95446726 |
| 125 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.95174958 |
| 126 | Bladder diverticulum (HP:0000015) | 1.95139357 |
| 127 | Ectopia lentis (HP:0001083) | 1.94658249 |
| 128 | Metabolic acidosis (HP:0001942) | 1.93863512 |
| 129 | Distal lower limb muscle weakness (HP:0009053) | 1.93040660 |
| 130 | Abdominal distention (HP:0003270) | 1.92674595 |
| 131 | Septate vagina (HP:0001153) | 1.92267241 |
| 132 | Enlarged kidneys (HP:0000105) | 1.92135528 |
| 133 | Abnormal gallbladder morphology (HP:0012437) | 1.91801843 |
| 134 | Fragile nails (HP:0001808) | 1.90095416 |
| 135 | Hydroxyprolinuria (HP:0003080) | 1.89443497 |
| 136 | Abnormality of proline metabolism (HP:0010907) | 1.89443497 |
| 137 | Abnormality of the acetabulum (HP:0003170) | 1.88497965 |
| 138 | Short nail (HP:0001799) | 1.87817049 |
| 139 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.86480082 |
| 140 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.86081974 |
| 141 | Cholelithiasis (HP:0001081) | 1.82846013 |
| 142 | Back pain (HP:0003418) | 1.82436150 |
| 143 | Abnormal hand bone ossification (HP:0010660) | 1.81233320 |
| 144 | Glycosuria (HP:0003076) | 1.80901730 |
| 145 | Abnormality of urine glucose concentration (HP:0011016) | 1.80901730 |
| 146 | Cerebral aneurysm (HP:0004944) | 1.79713116 |
| 147 | Delayed CNS myelination (HP:0002188) | 1.79401887 |
| 148 | Irritability (HP:0000737) | 1.79359799 |
| 149 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.78950763 |
| 150 | Joint stiffness (HP:0001387) | 1.78841354 |
| 151 | Buphthalmos (HP:0000557) | 1.78400289 |
| 152 | Abnormal hemoglobin (HP:0011902) | 1.78162249 |
| 153 | Neonatal onset (HP:0003623) | 1.77739766 |
| 154 | Neonatal short-limb short stature (HP:0008921) | 1.76861484 |
| 155 | Glomerulosclerosis (HP:0000096) | 1.76803852 |
| 156 | Turricephaly (HP:0000262) | 1.76742118 |
| 157 | Pancreatitis (HP:0001733) | 1.76696627 |
| 158 | Insulin resistance (HP:0000855) | 1.76368336 |
| 159 | Abnormal tarsal ossification (HP:0008369) | 1.76357465 |
| 160 | Cerebral edema (HP:0002181) | 1.76340701 |
| 161 | Amyloidosis (HP:0011034) | 1.75876232 |
| 162 | Opisthotonus (HP:0002179) | 1.75425245 |
| 163 | Sparse eyelashes (HP:0000653) | 1.73737709 |
| 164 | Abnormal ossification of hand bones (HP:0005921) | 1.73700829 |
| 165 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 1.70738094 |
| 166 | Pterygium (HP:0001059) | 1.70012575 |
| 167 | Aneurysm (HP:0002617) | 1.69946986 |
| 168 | Plantar hyperkeratosis (HP:0007556) | 1.67077030 |
| 169 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.65240346 |
| 170 | Joint laxity (HP:0001388) | 1.65219102 |
| 171 | Neonatal death (HP:0003811) | 1.64869898 |
| 172 | Long toe (HP:0010511) | 1.63870633 |
| 173 | Microglossia (HP:0000171) | 1.63425788 |
| 174 | Hypotrichosis (HP:0001006) | 1.61832285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.06368779 |
| 2 | ERN1 | 3.57866107 |
| 3 | EPHA2 | 3.51916589 |
| 4 | BCKDK | 3.24182463 |
| 5 | MST1R | 2.90921743 |
| 6 | FGFR4 | 2.55777616 |
| 7 | FER | 2.42208441 |
| 8 | LATS1 | 2.38574060 |
| 9 | SIK1 | 2.34163150 |
| 10 | LATS2 | 2.20842718 |
| 11 | TRIB3 | 2.12383454 |
| 12 | ERBB4 | 2.10685329 |
| 13 | DDR2 | 2.02201718 |
| 14 | EPHB2 | 1.93191829 |
| 15 | PTK2 | 1.88741645 |
| 16 | PIK3CG | 1.74896203 |
| 17 | SCYL2 | 1.72603145 |
| 18 | MET | 1.71328354 |
| 19 | EIF2AK1 | 1.70265988 |
| 20 | PAK3 | 1.66270384 |
| 21 | TESK1 | 1.65527084 |
| 22 | MAP2K1 | 1.60057532 |
| 23 | PTK6 | 1.55803064 |
| 24 | TAOK3 | 1.54670738 |
| 25 | STK38L | 1.54217658 |
| 26 | MAPKAPK3 | 1.47838438 |
| 27 | MAP3K2 | 1.47019688 |
| 28 | PDGFRA | 1.44039332 |
| 29 | EPHA3 | 1.43230407 |
| 30 | STK38 | 1.41772712 |
| 31 | MYLK | 1.37374044 |
| 32 | PKN2 | 1.36889872 |
| 33 | INSRR | 1.33331359 |
| 34 | PIM2 | 1.23888511 |
| 35 | PIK3CA | 1.22728892 |
| 36 | DMPK | 1.22643936 |
| 37 | ICK | 1.21604180 |
| 38 | MOS | 1.21069273 |
| 39 | LMTK2 | 1.20028193 |
| 40 | MAP2K4 | 1.19486631 |
| 41 | MAPK15 | 1.18603667 |
| 42 | MAP2K2 | 1.18015497 |
| 43 | MAP3K3 | 1.15238757 |
| 44 | PTK2B | 1.15136316 |
| 45 | LIMK1 | 1.12005438 |
| 46 | ARAF | 1.11564435 |
| 47 | KSR2 | 1.08640471 |
| 48 | MAP3K9 | 1.05602316 |
| 49 | TTN | 1.03832064 |
| 50 | RIPK1 | 1.03058269 |
| 51 | ILK | 1.02737304 |
| 52 | PDGFRB | 1.01874557 |
| 53 | FGFR2 | 1.01530081 |
| 54 | EPHA4 | 0.99431965 |
| 55 | NME1 | 0.96419577 |
| 56 | NEK9 | 0.95979411 |
| 57 | ABL2 | 0.94663836 |
| 58 | NTRK1 | 0.94151109 |
| 59 | ERBB2 | 0.86045924 |
| 60 | PAK2 | 0.84121231 |
| 61 | MAP3K12 | 0.81783712 |
| 62 | MAP3K1 | 0.75957289 |
| 63 | KDR | 0.74903472 |
| 64 | PRKD2 | 0.74575692 |
| 65 | CAMK2G | 0.73460131 |
| 66 | DYRK1B | 0.73106381 |
| 67 | TESK2 | 0.72310584 |
| 68 | PRKG2 | 0.70820502 |
| 69 | MAP3K11 | 0.69449046 |
| 70 | TRPM7 | 0.67500038 |
| 71 | EPHB1 | 0.66218348 |
| 72 | PAK4 | 0.65791425 |
| 73 | RET | 0.65625333 |
| 74 | JAK1 | 0.62090229 |
| 75 | RPS6KB2 | 0.60292484 |
| 76 | FGFR3 | 0.59522208 |
| 77 | CAMK2B | 0.59222549 |
| 78 | NEK6 | 0.59113467 |
| 79 | MAPK11 | 0.58510136 |
| 80 | GRK5 | 0.57028027 |
| 81 | DAPK2 | 0.56819163 |
| 82 | MUSK | 0.56490104 |
| 83 | PRKCI | 0.56487882 |
| 84 | NME2 | 0.56063540 |
| 85 | ROCK2 | 0.54793139 |
| 86 | RPS6KA2 | 0.54743032 |
| 87 | ROCK1 | 0.54384241 |
| 88 | EIF2AK3 | 0.54227626 |
| 89 | FGFR1 | 0.53860091 |
| 90 | TGFBR2 | 0.53304926 |
| 91 | CAMK2D | 0.49312588 |
| 92 | CDC42BPA | 0.48310044 |
| 93 | LRRK2 | 0.48225129 |
| 94 | RPS6KA4 | 0.46567928 |
| 95 | BMX | 0.46560940 |
| 96 | BRAF | 0.46504488 |
| 97 | CDK6 | 0.46488888 |
| 98 | PRKCZ | 0.44854662 |
| 99 | MAP3K7 | 0.44301166 |
| 100 | ZAP70 | 0.43766682 |
| 101 | DAPK3 | 0.43640339 |
| 102 | WNK4 | 0.42298969 |
| 103 | CAMK2A | 0.41733079 |
| 104 | PNCK | 0.41567554 |
| 105 | GRK1 | 0.41407497 |
| 106 | PRKCE | 0.40493525 |
| 107 | FLT3 | 0.39981325 |
| 108 | CHUK | 0.39043473 |
| 109 | MAP3K13 | 0.38949092 |
| 110 | HIPK2 | 0.38000647 |
| 111 | AKT3 | 0.37655146 |
| 112 | SIK3 | 0.35608082 |
| 113 | MAPKAPK2 | 0.35109277 |
| 114 | SGK3 | 0.33622881 |
| 115 | IGF1R | 0.33432541 |
| 116 | TAOK2 | 0.33133069 |
| 117 | GSK3A | 0.33081812 |
| 118 | PRKD1 | 0.32726575 |
| 119 | PRKAA2 | 0.31894701 |
| 120 | JAK2 | 0.31315833 |
| 121 | KSR1 | 0.31165054 |
| 122 | ADRBK1 | 0.30561180 |
| 123 | SRC | 0.30217017 |
| 124 | STK3 | 0.29313486 |
| 125 | MST4 | 0.29233546 |
| 126 | TAOK1 | 0.28571539 |
| 127 | STK39 | 0.27378921 |
| 128 | INSR | 0.26725916 |
| 129 | PDK2 | 0.26441300 |
| 130 | NTRK3 | 0.26247069 |
| 131 | GRK6 | 0.26179352 |
| 132 | MTOR | 0.26019880 |
| 133 | STK24 | 0.25180035 |
| 134 | CDK8 | 0.25073615 |
| 135 | TSSK6 | 0.24889547 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.17922967 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.30908546 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.26169114 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.92058464 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.67994960 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.51286550 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.49649098 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.46315334 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.32745517 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.20957947 |
| 11 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.17836580 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.17562776 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.14293417 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.13476456 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.10461579 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.08526762 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.04007474 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.03053662 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.96451327 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.96281815 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.93021788 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.79416363 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.79096628 |
| 24 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.73562909 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.63262394 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.62366643 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.60815532 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.50961907 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49472097 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.48110835 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.46796279 |
| 32 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.45468944 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.45467868 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44801297 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.42350886 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.41666147 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.39058161 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33183732 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32868228 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.31754191 |
| 41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.28579843 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.24837967 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23110450 |
| 44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.22124625 |
| 45 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.21973441 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18659267 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.18225383 |
| 48 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.14155526 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11744797 |
| 50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.09243244 |
| 51 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.04190241 |
| 52 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.03062502 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02784754 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97789289 |
| 55 | Thyroid cancer_Homo sapiens_hsa05216 | 0.97456782 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96468517 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96385891 |
| 58 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.95485022 |
| 59 | Carbon metabolism_Homo sapiens_hsa01200 | 0.92984055 |
| 60 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91062439 |
| 61 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.89224380 |
| 62 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.87207822 |
| 63 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.85084845 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84952360 |
| 65 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.83413178 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82338524 |
| 67 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.80567986 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.79159136 |
| 69 | Lysosome_Homo sapiens_hsa04142 | 0.77566666 |
| 70 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.76384615 |
| 71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74025061 |
| 72 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.73575331 |
| 73 | Circadian rhythm_Homo sapiens_hsa04710 | 0.71742021 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70993103 |
| 75 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.70941141 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70672010 |
| 77 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66149641 |
| 78 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.66009196 |
| 79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65562859 |
| 80 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65489420 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64676950 |
| 82 | Axon guidance_Homo sapiens_hsa04360 | 0.64619683 |
| 83 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.64609660 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.64374004 |
| 85 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.64125777 |
| 86 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63465272 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63048005 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.61449494 |
| 89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61365625 |
| 90 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.61341515 |
| 91 | Hepatitis C_Homo sapiens_hsa05160 | 0.61311687 |
| 92 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58876183 |
| 93 | Bladder cancer_Homo sapiens_hsa05219 | 0.58796041 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.50864626 |
| 95 | Melanoma_Homo sapiens_hsa05218 | 0.50345916 |
| 96 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.50180115 |
| 97 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.50058279 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.49250275 |
| 99 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.46339560 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.45907135 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44235647 |
| 102 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.40368202 |
| 103 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39862283 |
| 104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37949837 |
| 105 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37810308 |
| 106 | Protein export_Homo sapiens_hsa03060 | 0.37594970 |
| 107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36486115 |
| 108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.34514607 |
| 109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33974654 |
| 110 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.33550328 |
| 111 | Lysine degradation_Homo sapiens_hsa00310 | 0.31101333 |
| 112 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.30616676 |
| 113 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.30557679 |
| 114 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.28236610 |
| 115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.25959303 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.25850256 |
| 117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.24929535 |
| 118 | Amoebiasis_Homo sapiens_hsa05146 | 0.22096632 |
| 119 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.21879735 |
| 120 | Tight junction_Homo sapiens_hsa04530 | 0.19685986 |
| 121 | Adherens junction_Homo sapiens_hsa04520 | 0.18212493 |
| 122 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.17790618 |
| 123 | Insulin resistance_Homo sapiens_hsa04931 | 0.17355487 |
| 124 | Focal adhesion_Homo sapiens_hsa04510 | 0.16448361 |
| 125 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.16074765 |
| 126 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.12468712 |
| 127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.10983068 |
| 128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10504781 |
| 129 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.07088695 |
| 130 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.04397301 |
| 131 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.03628652 |
| 132 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03150277 |
| 133 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.02783453 |
| 134 | Insulin secretion_Homo sapiens_hsa04911 | 0.01944711 |

